{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:40:52Z","timestamp":1788921652663,"version":"build-2803163510"},"reference-count":0,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s12185-025-04045-6","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T03:56:44Z","timestamp":1755575804000},"page":"465-509","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["JSH practical guidelines for hematological malignancies, 2023 III. Myeloma 1. Multiple myeloma (MM)"],"prefix":"10.1007","volume":"122","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4951-960X","authenticated-orcid":false,"given":"Shinsuke","family":"Iida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutaka","family":"Sunami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Takamatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Tsukada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Hosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Miki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,19]]},"updated-by":[{"DOI":"10.1007\/s12185-025-04107-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000}}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-025-04045-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-025-04045-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-025-04045-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T06:37:19Z","timestamp":1765175839000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-025-04045-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,19]]},"references-count":0,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["4045"],"URL":"https:\/\/doi.org\/10.1007\/s12185-025-04045-6","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,19]]},"assertion":[{"value":"27 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised to update the table 1.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":9,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":10,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s12185-025-04107-9","URL":"https:\/\/doi.org\/10.1007\/s12185-025-04107-9","order":12,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"SI\n                      1)\n                      has received per diem, including speaking fees, from Janssen Pharmaceutical, Bristol Myers Squibb, Sanofi, Takeda Pharmaceuticals, and Ono Pharmaceutical; has received research funding from Janssen Pharmaceutical, Bristol Myers Squibb, Sanofi, Takeda Pharmaceuticals, Ono Pharmaceutical, Pfizer, Novartis Pharma, Daiichi Sankyo, Celgene, Kyowa Kirin, Amgen, AbbVie, GlaxoSmithKline, and Alexion Pharmaceuticals; and has received scholarship or grant donations from Chugai Pharmaceutical. SI\n                      2)\n                      has received per diem, including speaking fees, from Bristol Myers Squibb, Janssen Pharmaceutical, Takeda Pharmaceuticals, Sanofi, Ono Pharmaceutical, and Chugai Pharmaceutical; has received research funding from Meiji Seika Pharma, Kissei Pharmaceutical, Sanofi, AbbVie, Bristol Myers Squibb, Janssen Pharmaceutical, Parexel International, CMIC, and ICON Clinical Research; and has received scholarship or grant donations from Chugai Pharmaceutical, Asahi Kasei Pharma, Eisai, Bayer Yakuhin, Kyowa Kirin, Shionogi, and Ono Pharmaceutical. KS has received per diem, including speaking fees, from Ono Pharmaceutical, Janssen Pharmaceutical, Sanofi, Bristol Myers Squibb, and Celgene; and has received research funding from Ono Pharmaceutical, MSD, Celgene, AbbVie, Takeda Pharmaceuticals, Sanofi, Janssen Pharmaceutical, GlaxoSmithKline, Chugai Pharmaceutical, Novartis Pharma, Otsuka Pharmaceutical, Bristol Myers Squibb, Pfizer, Kyowa Kirin, Parexel International, Astellas Pharma, and Amgen. HT serves as a director or advisor for SRL; has received per diem, including speaking fees, from Janssen Pharmaceutical, Sanofi, Ono Pharmaceutical, and Bristol Myers Squibb; and has received research funding from Bristol Myers Squibb. NT has received per diem, including speaking fees, from Janssen Pharmaceutical and Sanofi; and has received research funding from Sanofi. NH has received research funding from Otsuka Pharmaceutical and Chugai Pharmaceutical; and has received scholarship or grant donations from Chugai Pharmaceutical, Kyowa Kirin, Shionogi, Asahi Kasei Pharma, Otsuka Pharmaceutical, Nippon Shinyaku, Eisai, Takeda Pharmaceuticals, Teijin Pharma, Ono Pharmaceutical, and Mochida Pharmaceutical. HM has no conflicts of interest to report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}